Clinical Trials Browser

Phase 2 × Drug-Related Side Effects and Adverse Reactions × Genitourinary × Clear all

NCT02324803 2014-12-24

Phase II Study of Pazopanib as Second-line Treatment After Sunitinib in mRCC Patients

Phase 2 Unknown

Carcinoma, Renal Cell, Drug-Related Side Effects and Adverse Reactions

NCT00006105 2013-09-05

Gemcitabine, Cisplatin, and Amifostine Following Surgery in Treating Patients With Locally Advanced Bladder Cancer

Phase 2 Completed

Urinary Bladder Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT00003811 2013-07-04

Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumors

Phase 2 Completed

GenitourinaryGynecologic

Ovarian Germ Cell Cancer, Ovarian Neoplasms, Teratoma, Testicular Neoplasms, Drug-Related Side Effects and Adverse Reactions